Notable Analyst Rating Changes 9/8: (LLY) (ENB) (JCI) Upgraded; (NKE) (ABBV) (AAPL) Downgraded
JPMorgan upgraded Eli Lilly (NYSE: LLY) from Neutral to Overweight with a price target of $95.Goldman Sachs upgraded Enbridge ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)